Max Planck Society - eDoc Server

http://edoc.mpg.de



Causal therapy of Parkinson's disease with anle138b, a novel protein aggregation inhibitor.
Authors: Levin, J.; Wagner, J.; Ryazanov, S.; Leonov, A.; Shi, S.; Schmidt, F.; Prix, C.; Bertsch, U.; Mitteregger-Kretzschmar, G.; Geissen, M.; Hischberger, T.; Tavan, P.; Pilger, J.; Zweckstetter, M.; Frank, T.; Baehr, M.; Weishaupt, J.; Uhr, M.; Urlaub, H.; Teichmann, U.; Boetzel, K.; Groschup, M.; Kretzschmar, H. A.; Griesinger, C.; Giese, A.
Date of Publication (YYYY-MM-DD): 2011-05
Name of Conference/Meeting: 15th International Congress of Parkinsons Disease and Movement Disorders
Title of Journal: Movement Disorders
Volume (in Journal): 26
Issue / Number: Supplement 2
Start Page: S21
End Page: S21
Document Type: Conference-Paper
ID: 579653.0


The developmental expression of vasoactive intestinal peptide (VIP) in cholinergic sympathetic neurons depends on cytokines signaling through LIFR β-containing receptors
Authors: Duong, C. V.; Geissen, M.; Rohrer, H.
Date of Publication (YYYY-MM-DD): 2002
Title of Journal: Development
Volume: 129
Issue / Number: 6
Start Page: 1387
End Page: 1396
Document Type: Article
ID: 10505.0